Zobrazeno 1 - 3 of 3 pro vyhledávání: '"John W Firth"'
1
Validation of a highly sensitive ICP-MS method for the determination of platinum in biofluids: application to clinical pharmacokinetic studies with oxaliplatin
Autor: J.Gilmour Morrison, Martin A. Graham, Peter White, Dennis Greenslade, Steve G Woolfrey, John W Firth, Sophie McDougall
Publikováno v: Journal of Pharmaceutical and Biomedical Analysis. 24:1-10
ELOXATIN (Oxaliplatin) is a novel platinum containing anti-cancer agent with a diaminocyclohexane carrier ligand which has been approved in several major European countries. Clinical studies have demonstrated that the compound exhibits marked activit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::476e08ad13b6e04193402a57a99421cd
https://doi.org/10.1016/s0731-7085(00)00377-0
Zobrazit plný text záznamu
2
Degradation studies under neutral and basic conditions on ciprofibrate, an orally active hypolipidemic agent containing a (4-alkoxyaryl)-1,1-dichlorocyclopropane unit
Autor: Juma'a R. Al Dulayymi, George J. Ellames, Louisa M. Wrench, John M. Herbert, G. Carr, Mark S. Baird, Margaret A. Donald, John W. Firth, Petar R. Vojvodic, Stephen J. Byard
Publikováno v: J. Chem. Soc., Perkin Trans. 2. :43-48
The major product of degradation of ciprofibrate (1), 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid, in aqueous sodium hydroxide under reflux is 2-[4-(3-hydroxypropynyl)-phenoxy]-2-methylpropanoic acid (11). A further product, 2-(4-et
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d735971293306f804bc55a6b9dbf3354
https://doi.org/10.1039/p29930000043
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje